Institute of Science Tokyo · Graduate School of Medical and Dental Sciences · 准教授

Research keywordsmultiple system atrophy・Guillain-Barre syndrome・multiple sclerosis・neuroimmunology・neuromuscular disorders・clinical trials・registry studies・respiratory failure

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T. Slowly expanding lesions are associated with disease activity and gray matter loss in relapse-onset multiple sclerosis. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2024.11; 34 (6): 758-765. ( PubMed , DOI )2024
• Yokote H, Miyazaki Y, Fujimori J, Nishida Y, Toru S, Niino M, Nakashima I, Miura Y, Yokota T. Characterization of Japanese multiple sclerosis patients with progression independent of relapse activity: A 2-year multicenter cohort study. Journal of neuroimmunology. 2024.09; 394 578407. ( PubMed , DOI )2024
• Kuwabara S, Kusunoki S, Kuwahara M, Yamano Y, Nishida Y, Ishida H, Kasuya T, Kupperman E, Lin Q, Frick G, Misawa S. Efficacy and safety of eculizumab in Guillain-Barré syndrome: A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial. Journal of the peripheral nervous system : JPNS. 2024.09; 29 (3): 339-349. ( PubMed , DOI )2024
• Okamoto T, Ishizuka T, Shimizu R, Asahina Y, Nakamura H, Shimizu Y, Nishida Y, Yokota T, Lin Y, Sato W, Yamamura T. Efficacy and Safety of the Natural Killer T Cell-Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial. JMIR research protocols. 2024.01; 13 e46709. ( PubMed , DOI )2024

• Official profile